Recherche
-
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis
(Journal of Neurology. vol. 268, n° 2, pp. 669-679, 2021-02)Article de revue -
Insights on the Relationship Between Hippocampal Connectivity and Memory Performances at the Early Stage of Multiple Sclerosis
(Frontiers in Neurology. vol. 12, 2021-05-19)Article de revueLibre accès -
The radiologically isolated syndrome: revised diagnostic criteria
(Brain - A Journal of Neurology, 2023-03-02)Article de revue -
Structural constraints of functional connectivity drive cognitive impairment in the early stages of multiple sclerosis
(Multiple Sclerosis Journal. vol. 27, n° 4, pp. 559-567, 2021-04)Article de revue -
Amygdala network reorganization mediates the theory of mind performances in multiple sclerosis
(Journal of Neuroscience Research. vol. 100, n° 2, pp. 537-550, 2022-02)Article de revue -
Altered functional brain states predict cognitive decline 5 years after a clinically isolated syndrome
(Multiple Sclerosis Journal. vol. 28, n° 12, pp. 1973-1982, 2022-10)Article de revue -
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
(CNS drugs. vol. 35, n° 11, pp. 1217-1232, 2021-11)Article de revue -
Comparison of 2 Methods for Estimating Multiple Sclerosis-Related Mortality: The Excess Mortality vs the Cause-Specific Frameworks
(Neurology. vol. 101, n° 24, pp. E2483-E2496, 2023-12-12)Article de revue -
A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica
(Annals of Clinical and Translational Neurology. vol. 8, n° 10, pp. 2025-2037, 2021-10)Article de revueLibre accès -
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
(Neurology. vol. 8, n° 4, 2021-04-26)Article de revueLibre accès